HIPO Hippo Holdings Inc.
$32.00▼ -0.19%
Financials
Other
After hours
$32.00▲ +0.04%
Sep 11, 4:01 PM ET
Volume 92.9K
Avg Volume (10D) 172.5K
Key Metrics & Fundamentals
Market Cap
$844.46M
P/E Ratio
6.8
Div Yield
–%
52W Range
24.08 - 38.98
% vs 50 MA
2.14%
% vs 200 MA
10.54%
RSI-14
46.3
MACD Histogram
-0.3000
Beta (1Y vs SPY)
0.75
Free Cash Flow
$39.80M
Gross Rev
$144.70M
Gross Profit
$144.70M
EBITDA
–
COGS
–
Operating Exp
–
Operating Income
–
EBIT
–
Pretax Income
$11.00M
Net Income
$10.10M
EPS (Diluted)
0.38
Price & Volume History
Loading chart…
Recent News

The Case for Holding MetLife Stock: What Investors Need to Know
Zacks · Sep 3, 2026 3:02 PM
Hippo to Expand Homeowners Insurance Program to 14 new US States
MT Newswires · Aug 27, 2026 4:56 PM

Hippo to Expand Homeowners Insurance Footprint in Next Phase of Profitable Growth
PR Newswire · Aug 27, 2026 12:00 PM

Wall Street Analysts Believe Hippo Holdings (HIPO) Could Rally 25.89%: Here's is How to Trade
Zacks · Aug 26, 2026 1:55 PM

Here's Why Investors Should Stay Invested in Aflac Stock for Now
Zacks · Aug 14, 2026 2:50 PM

Here's Why CNO Financial Shares Are Attracting Prudent Investors Now
Zacks · Aug 12, 2026 3:35 PM

Marsh's MMA to Acquire Accel, Bolstering Midwest Insurance Reach
Zacks · Aug 11, 2026 3:59 PM
Can Hippo Holdings (HIPO) Run Higher on Rising Earnings Estimates?
Zacks · Aug 10, 2026 4:20 PM
Does Hippo Holdings (HIPO) Have the Potential to Rally 29.68% as Wall Street Analysts Expect?
Zacks · Aug 10, 2026 1:55 PM
Should You Buy, Sell or Hold ROOT Stock Post Q2 Earnings?
Zacks · Aug 6, 2026 5:56 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See HIPO's money flow as a full page
Social Sentiment
Avg -0.50 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.